Jarislowsky, Fraser Ltd’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$314K Hold
2,000
﹤0.01% 177
2025
Q2
$336K Hold
2,000
﹤0.01% 172
2025
Q1
$276K Sell
2,000
-250
-11% -$31.9K ﹤0.01% 175
2024
Q4
$266K Hold
2,250
﹤0.01% 180
2024
Q3
$249K Hold
2,250
﹤0.01% 179
2024
Q2
$221K Hold
2,250
﹤0.01% 176
2024
Q1
$252K Sell
2,250
-200
-8% -$21.6K ﹤0.01% 183
2023
Q4
$247K Hold
2,450
﹤0.01% 211
2023
Q3
$213K Hold
2,450
﹤0.01% 184
2023
Q2
$232K Buy
+2,450
New +$207K ﹤0.01% 190
2023
Q1
Sell
-2,950
Closed -$227K 199
2022
Q4
$227K Buy
+2,950
New +$224K ﹤0.01% 198
2022
Q1
Sell
-8,000
Closed -$411K 211
2021
Q4
$411K Sell
8,000
-5,000
-38% -$245K ﹤0.01% 191
2021
Q3
$642K Hold
13,000
﹤0.01% 186
2021
Q2
$742K Hold
13,000
﹤0.01% 182
2021
Q1
$789K Hold
13,000
﹤0.01% 173
2020
Q4
$696K Hold
13,000
﹤0.01% 175
2020
Q3
$610K Sell
13,000
-4,000
-24% -$205K ﹤0.01% 172
2020
Q2
$887K Sell
17,000
-3,950
-19% -$204K 0.01% 160
2020
Q1
$1M Sell
20,950
-5,900
-22% -$306K 0.01% 152
2019
Q4
$1.36M Sell
26,850
-3,100
-10% -$160K 0.01% 149
2019
Q3
$1.41M Sell
29,950
-5,200
-15% -$237K 0.01% 149
2019
Q2
$1.66M Sell
35,150
-19,150
-35% -$883K 0.01% 142
2019
Q1
$2.61M Sell
54,300
-41,600
-43% -$2.08M 0.02% 128
2018
Q4
$4.28M Sell
95,900
-23,755
-20% -$1.24M 0.03% 114
2018
Q3
$6.05M Sell
119,655
-10,912
-8% -$558K 0.04% 113
2018
Q2
$6.38M Sell
130,567
-4,085
-3% -$232K 0.04% 113
2018
Q1
$8.44M Sell
134,652
-1,050
-0.8% -$72K 0.05% 103
2017
Q4
$8.31M Sell
135,702
-1,882
-1% -$116K 0.05% 109
2017
Q3
$9.21M Buy
137,584
+357
+0.3% +$25.2K 0.06% 109
2017
Q2
$10.7M Sell
137,227
-800
-0.6% -$60.4K 0.07% 106
2017
Q1
$11.3M Sell
138,027
-700
-0.5% -$55.1K 0.07% 106
2016
Q4
$9.98M Sell
138,727
-12,300
-8% -$889K 0.06% 109
2016
Q3
$11.7M Sell
151,027
-2,259,453
-94% -$183M 0.08% 101
2016
Q2
$200M Buy
2,410,480
+2,259,453
+1,496% +$180M 1.39% 19
2016
Q1
$12.4M Hold
151,027
0.09% 101
2015
Q4
$13.5M Hold
151,027
0.1% 96
2015
Q3
$11.6M Hold
151,027
0.09% 96
2015
Q2
$12.6M Hold
151,027
0.09% 96
2015
Q1
$13.6M Sell
151,027
-10,385
-6% -$894K 0.09% 93
2014
Q4
$13M Buy
161,412
+35
+0% +$2.76K 0.08% 96
2014
Q3
$12.1M Hold
161,377
0.07% 97
2014
Q2
$11.1M Sell
161,377
-200
-0.1% -$13.6K 0.06% 96
2014
Q1
$11.3M Sell
161,577
-275
-0.2% -$19.1K 0.07% 97
2013
Q4
$10.8M Sell
161,852
-1,550
-0.9% -$94.7K 0.06% 97
2013
Q3
$8.52M Sell
163,402
-5,225
-3% -$265K 0.05% 97
2013
Q2
$7.96M Buy
+168,627
New +$7.7M 0.05% 95

Other funds holding CAH

Jarislowsky, Fraser Ltd's CAH Position: Q3 2025 in Review

Jarislowsky, Fraser Ltd held its Cardinal Health (CAH) position steady in Q3 2025 at 2,000 shares worth $314K. The position accounts for ﹤0.01% of the portfolio, ranked #177.

Jarislowsky, Fraser Ltd first reported a position in CAH in Q2 2013 and has held it in 46 quarters since. The position peaked at $200M in Q2 2016. 1,222 funds tracked by Wall St. Rank hold CAH as of Q3 2025.

  • Jarislowsky, Fraser Ltd held 2,000 shares of Cardinal Health worth $314K as of Q3 2025.
  • Jarislowsky, Fraser Ltd left its Cardinal Health share count unchanged in Q3 2025.
  • Cardinal Health made up ﹤0.01% of Jarislowsky, Fraser Ltd's portfolio in Q3 2025, its #177 holding.
  • Jarislowsky, Fraser Ltd first reported a position in Cardinal Health in Q2 2013 and has held it in 46 quarters since.
  • Jarislowsky, Fraser Ltd's Cardinal Health position peaked at $200M in Q2 2016.
  • 1,222 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2025.

Based on Jarislowsky, Fraser Ltd's 13F filing for Q3 2025, filed 21 Oct 2025.